Regulatory News
Tuesday, December 13, 2016
As drug approvals dive in 2016, returns on R&D deteriorate
LONDON, Dec 13 (Reuters) - The global pharmaceuticals
industry is set to win the lowest annual number of new drug
approvals this year since 2010 and a new report on Tuesday
suggests drugmakers'...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment